-
EGRX Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Eagle Pharmaceuticals (EGRX)
Company Profile
Quarter (USD) | Jun 23 | Mar 23 | Dec 22 | Sep 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 15.35 mm | 15.35 mm | 15.35 mm | 15.35 mm | 15.35 mm | 15.35 mm |
Cash burn (monthly) | 2.18 mm | 1.77 mm | (no burn) | (no burn) | 42.00 k | 776.50 k |
Cash used (since last report) | 38.82 mm | 31.46 mm | n/a | n/a | 747.54 k | 13.82 mm |
Cash remaining | -23.46 mm | -16.10 mm | n/a | n/a | 14.61 mm | 1.53 mm |
Runway (months of cash) | -10.8 | -9.1 | n/a | n/a | 347.8 | 2.0 |
13F holders | Current |
---|---|
Total holders | 66 |
Opened positions | 12 |
Closed positions | 23 |
Increased positions | 11 |
Reduced positions | 27 |
13F shares | Current |
---|---|
Total value | 31.71 bn |
Total shares | 9.55 mm |
Total puts | 100.00 |
Total calls | 1.00 mm |
Total put/call ratio | 0.0 |
Largest owners | Shares | Value |
---|---|---|
Nantahala Capital Management | 2.36 mm | $8.79 bn |
AIGH Capital Management | 1.21 mm | $4.52 bn |
C Citigroup | 1.00 mm | $3.73 bn |
Scott Tarriff | 992.62 k | $0.00 |
Vanguard | 579.51 k | $2.16 bn |
Aqr Capital Management | 374.99 k | $1.40 bn |
BLK BlackRock | 268.17 k | $1.00 bn |
Renaissance Technologies | 256.35 k | $956.19 mm |
Marshall Wace | 223.35 k | $833.11 mm |
MS Morgan Stanley | 192.21 k | $716.96 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
5 Jan 24 | Scott Tarriff | Common Stock | Payment of exercise | Dispose F | No | No | 5.13 | 4,322 | 22.17 k | 541,125 |
5 Jan 24 | Brian Joseph Cahill | Common Stock | Payment of exercise | Dispose F | No | No | 5.13 | 735 | 3.77 k | 46,681 |
21 Dec 23 | Michael Graves | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 5.01 | 293,000 | 1.47 mm | 293,000 |
18 Dec 23 | Brian Joseph Cahill | Common Stock | Payment of exercise | Dispose F | No | No | 4.76 | 452 | 2.15 k | 47,416 |